Prime diagnostic importance has been postulated for the measurement of free thyroxine in human serum. During the past decade various innovative and routinely applicable techniques have been developed for its assay, and claims for their superior performance in clinical practice have subsequently been made. However, in our opinion, based on current literature concerning thyroxine metabolism together with basic information about the physicochemical characteristics that govern its intravascular distribution, it seems appropriate to indicate caution against overestimating the diagnostic sensitivity attributed to free thyroxine measurement irrespective of assay methodology and its conceptual elegance.
SUMMARY. Prime diagnostic importance has been postulated for the measurement of free thyroxine in human serum. During the past decade various innovative and routinely applicable techniques have been developed for its assay, and claims for their superior performance in clinical practice have subsequently been made. However, in our opinion, based on current literature concerning thyroxine metabolism together with basic information about the physicochemical characteristics that govern its intravascular distribution, it seems appropriate to indicate caution against overestimating the diagnostic sensitivity attributed to free thyroxine measurement irrespective of assay methodology and its conceptual elegance.
The plasma distribution of certain biological molecules of low molecular weight (especially hormones) is determined by both the concentrations and affinities of their respective binding protein(s) and the presence of competing endogenous and/or exogenous molecules.
In general, it is assumed that molecular species which bind with high affinity to plasma proteins are unavailable for uptake by target cells, whereas the non-protein bound fraction is directly related to the amount available to target tissue, and hence this free fraction is considered the biologically active component in plasma. I. 2 This widely accepted view has provided the main impetus which prompted both public and commercial institutions to apply ingenious scientific and technical manoeuvres to develop simple routine techniques for measuring the minute amounts of circulating concentrations of free thyroxine (Ff 4 ) in human serum. 3 • 4 Additional support for this concept stemmed from numerous subsequent reports and re-views~7 which have demonstrated optimistic prospects for these diagnostic tools when applied in actual clinical circumstances. In contrast, discrepancies between serum Ff 4
Correspondence: Dr Mithal Hassan, Nuclear Medicine Department, Faculty of Medicine, Kuwait University, P.O. Box 24923 (Safat), 13110 Kuwait. levels and the actual thyrometabolic status, 8. 9 or significant technical limitations in various commercially available assays have also been described.v 10. II However, in the context of diagnostic usefulness, the combination of theoretical considerations, current knowledge on the metabolism! control of thyroid hormones and our practical experience have led us to review the evidence supporting the validity of some of the assumptions that suggest a better diagnostic utility for free T 4 assay.
Physicochemkal interactions
The association of any biologically active substance with a serum protein involves the formation of non-covalent low energy dissociable bonds. Such interaction is characterised by a number of physicochemical parameters, of which probably the most important is the equilibrium constant (K) and its composites (association and dissociation constants). These constants refer to the kinetics of the reaction between the substance and its binding protein; it is generally assumed that the binding between the two, at equilibrium, is a reversible one and governed by the Law of Mass Action. 2 In practice, thyroxine is bound to a mixture of proteins, some specific and characterised by high affinity and low capacity (thyroxine bind-336 Al-Awqati and Hassan ing globulin, TBG and thyroxine binding prealbumin, TBPA); and another, more general, with a low affinity, but high capacity (albumin, Alb). Under conditions of undisturbed equilibrium, absence of competition from other biologic molecules and no loss of hormone into the extravascular compartment, the free hormone concentrations can be given by:
ine concentration can be calculated as follows: In order to estimate the free thyroxine concentration by substituting available data in Equation (1), the following derivations and approximations were made:
(a) The numerator denotes the concentration of all bound T4, which is equal to the difference between total T4 (TT4) and Ff 4 • Hence By utilising the information presented in Table 1 (data were primarily obtained from Ekins 2 and Pearce and Byfield 7 ) , Fig. 1 illustrates a computerised graphical solution to Equation (8) at low, normal and high TBG levels. The interesting phenomenon, concerning the ability of the system to absorb significant deviations in total thyroxine concentation, is clearly demonstrated and appears to be dependant on the levels of its binding proteins. Furthermore, the semi-exponential relationship between TT 4 and Ff 4 especially relevant at 
Reportedly.f under normal circumstances the distribution of T4 between the three proteins is roughly 76% bound to TBG, 16% bound to albumin and 8% bound to TBPA. Thus, Equation (3) can be approximated and rewritten:
(UTBG)=(TBG)-(0·76XTT 4)=A (4) and correspondingly, (UTBPA)=(TBPA)-(O·08XTT 4)=B (5) (UTAlb)=(Alb)-(O·16xTT 4)=C (6) By substituting Equations (2) (4) (5) and (6) in Equation (1), then the free thyrox- Hence, a positive three SO unit change in TT 4 concentration (from mean to mean +3 SO level, presumably causing a state of hyperthyroidism) will produce + 3·51 SO unit increase in FT4 concentration, while a negative change of the same magnitude in TT 4 (from mean to mean -3 SO level, presumably causing a state of hypothyroidism) will only produce a -2·6 SO unit decrease in FT 4 concentration. Furthermore, this proportional difference is of even greater scale in cases of increased plasma levels of the binding proteins such as occur in pregnancy and in patients on oral contraceptives, or as a consequence of genetically elevated rate of synthesis. In addition to their important physiologicand therapeutic implications, these theoretical observations would suggest that for optimum diagnostic sensitivity, the measurement of serum FT 4 is probably well suited for cases of hyperthyroidism, but it may be inferior to TT 4 assay in hypothyroidism.
This latter view was clearly and practically illustrated by a retrospective review of free and total thyroxine levels in patients with established thyrometabolic diseases. A receiver-
THYROID HORMONE ACTIVITY AT THE TISSUE LEVEL
An ideal test of thyroid function is expected to assess, specifically and sensitively, the metabolic availability and impact of thyroid hormones within the cellular compartment of their target tissues. However, in recent years it has become increasingly clear that triiodothyronine (T3) is the more active peripheral thyroid hormone General test criteria for diagnostic application
In order to provide a reliable definition of a thyrometabolic status or an answer to a question of consequence to patient management, the choice between serum TT4 or FT4 measurement obviously depends on the ability of each test to yield accurate and preferably direct information on any of the following main functional categories.
operating characteristic curve (Fig. 2) The well established fact that the thyroid gland is the only known source of T4 would, initially, infer the suitability of thyroxine measurement in serum (whether assayed as the total or the free fraction) to obtain a valid estimate of the 
Conclusion
The main purpose of this study is to critically appraise the notion that significant gains, in terms of diagnostic utility, can be expected whenever tests of free thyroxine are routinely applied to patients suspected of having thyroid metabolic dysfunction. The data presented in this report suggest, however, that such a preference for FT4 assay is amenable to challenge on both theoretical and practical levels (irrespective of the type of methodology employed for its measurement). Finally, we are aware that any statement concerning the diagnostic quality of these two tests is of a relative nature since precise and objective criteria for the individual thyrometabolic status cannot always be established unequivocally. Hence, a balanced appreciation of their respective advantages and limitations can greatly improve both the diagnostic utilisation and laboratory efficiency in routine clinical investigations.
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T$H HYPOTHALAMIC-PITUITARY FEEDBACK CONTROL Several factors are known to affect the secretion of thyrotropin (TSH), the prime regulator of thyroid gland activity. These include thyrotropin-releasing hormone and the dopaminergic inhibitory system. Furthermore, accumulating evidence suggests that controlled TSH secretion involves binding of T 3 to nuclear receptors, and that a substantial fraction of this T 3 is derived from intrapituitary monodeiodination of T 4 which was supplied from the circulation. Thus, it appears that plasma TI 4 and/or FT 4 (the exact role of each is still not clearly defined) are only indirectly related to TSH stimulation or suppression. However, this paper presents relevant information (Table 3) , obtained in both healthy euthyroid subjects and patients with various thyroid diseases, indicating that TSH was more significantly associated with serum concentrations of TI 4 than with . those of other thyroid parameters (i.e. FT 4 , T 3 or FT 3 ) . These findings provide additional support for the view that TI4 assay is probably more important than that of FT 4 when investigating the contribution of plasma hormones to the overall mechanism regulating TSH production. I, 10. 12. 13 
